
Retina
Latest News
Latest Videos

CME Content
More News

Additionally, the FDA approved a monthly dosing option for some patients who may benefit from resuming this schedule across approved indications.

Maturing of the vestibulo-ocular reflex is independent of sensory input.

Raman Bhakhri, OD, FAAO; Julie Rodman, OD, MS, FAAO; and Andrew Rixon, OD, provide retinal updates during the meeting.

Using storytelling to highlight inherited eye disease awareness: Inside the film "My Eyes"
The optometrist–turned filmmaker, Tsu Shan Chambers, discusses how her feature aims to improve public understanding of inherited retinal disease.

Eye care providers are uniquely positioned to catch early risks during routine exams.

Rodman is part of the faculty for a CE Spotlight Symposium that will focus on how extending dosing intervals can enhance the quality of life for patients with neovascular retinal disease.

Researchers will investigate a gene in the eye that is crucial for normal vision, but can cause retinal diseases when mutated that often lead to blindness.

FDA issues a complete response letter to Outlook Therapeutics for ONS-5010, citing insufficient evidence of effectiveness for wet AMD treatment.

Researchers found that patients with primary open-angle glaucoma have less agmatine and thiamine in the aqueous humor than patients without glaucoma.

Researchers used adaptive optics scanning light ophthalmoscopy (AOSLO) to study retinas in mice with photoreceptor damage, specifically photoreceptor laser injury.

A rare case of tubulointerstitial nephritis and uveitis syndrome in a teenager highlights the importance of multidisciplinary diagnosis and management.

Ocular salvage and preservation of vision are essentially dependent on early diagnosis, and several studies have been conducted to identify the factors leading to delayed diagnosis at presentation.

Better best-corrected visual acuity values and baseline thicker ganglion cell layer and retinal nerve fiber layer at ocular coherence tomography measurements were found to be the key predictive factors.


The latest in drug and technology developments and updates from July 2025.

The first-in-class, twice-daily topical formulation is intended for the treatment of nonproliferative diabetic retinopathy and diabetic macular edema.

Gyrate atrophy of the choroid and retina is a form of choroidal sclerosis and is a rare, progressive, autosomal recessive, inherited genetic disease that primarily affects the ocular tissue.

This will be the Flying Eye Hospital’s first visit to Rwanda.

From blue light blockers to sleep apnea, Jacqueline Theis, OD, FAAO, FNAP; and Joseph Allen, OD, FAAO, Dipl ABO, outlined how sleep can influence brain and ocular health, and vice versa.

The completion of the full BLA submission is anticipated in early 2026 and is eligible for priority review under the program’s fast-track designation.

New clinical trials reveal PER-001 as a groundbreaking treatment for glaucoma and diabetic retinopathy, showing significant vision improvements and safety.

Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.

Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.

Walkable communities could aid in reduction of type 2 diabetes.

A study reveals a genetic link between instant coffee consumption and increased risk of dry age-related macular degeneration, urging caution for high-risk individuals.























